Phase II Study of Gemcitabine, Carboplatin, and Bevacizumab in Patients With Advanced Unresectable or Metastatic Urothelial Cancer

PURPOSE: Although gemcitabine and carboplatin (GCa) is a standard option for patients with advanced urothelial cancer (UC) who are ineligible for cisplatin, outcomes remain poor. This trial evaluated the efficacy and safety of bevacizumab with GCa in advanced UC. PATIENTS AND METHODS: Patients with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Balar, Arjun V., Apolo, Andrea B., Ostrovnaya, Irina, Mironov, Svetlana, Iasonos, Alexia, Trout, Alisa, Regazzi, Ashley M., Garcia-Grossman, Ilana R., Gallagher, David J., Milowsky, Matthew I., Bajorin, Dean F.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2013
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3574268/
https://ncbi.nlm.nih.gov/pubmed/23341513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.42.5215
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados